Revista espanola de cardiologia最新文献

{"title":"Impacto de la exclusión de accesos transapicales en los resultados por sexos del implante percutáneo de válvula aórtica: ¿una limitación metodológica? Respuesta","authors":"Salvatore Brugaletta","doi":"10.1016/j.recesp.2025.06.007","DOIUrl":"10.1016/j.recesp.2025.06.007","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"78 10","pages":"Page 931"},"PeriodicalIF":5.9,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145181346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Corrección en el artículo del Grupo de Trabajo de la SEC y el Comité de Guías de la SEC «Comentarios a la guía ESC 2024 sobre el tratamiento de la presión arterial elevada y de la hipertensión», Rev Esp Cardiol. 2025;78:296-300","authors":"","doi":"10.1016/j.recesp.2025.05.011","DOIUrl":"10.1016/j.recesp.2025.05.011","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"78 8","pages":"Page 752"},"PeriodicalIF":5.9,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144714364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Picadura de escorpión sin síndrome de Kounis ni miocardiopatía de tako-tsubo","authors":"Regina Wilson , Halil Tekiner , Steven H. Yale , Eileen S. Yale","doi":"10.1016/j.recesp.2025.04.013","DOIUrl":"10.1016/j.recesp.2025.04.013","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"78 9","pages":"Pages 835-836"},"PeriodicalIF":5.9,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144895215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impacto de la exclusión de accesos transapicales en los resultados por sexos del implante percutáneo de válvula aórtica: ¿una limitación metodológica?","authors":"Lorenzo Fácila , Jezabel Pendás , Vicente Montagud , Miguel Benedito","doi":"10.1016/j.recesp.2025.05.017","DOIUrl":"10.1016/j.recesp.2025.05.017","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"78 10","pages":"Pages 930-931"},"PeriodicalIF":5.9,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145181347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Registro español de trasplante cardiaco. XXXVI informe oficial de la Asociación de Insuficiencia Cardiaca de la Sociedad Española de Cardiología","authors":"Francisco González-Vílchez ,&nbsp;Luis Almenar-Bonet ,&nbsp;Manuel Gómez-Bueno ,&nbsp;María G. Crespo-Leiro ,&nbsp;Manuel Cobo-Belaustegui ,&nbsp;Manuel Crespín-Crespín ,&nbsp;Carlos Ortiz-Bautista ,&nbsp;Juan F. Delgado-Jiménez ,&nbsp;Marta de Antonio-Ferrer ,&nbsp;José Manuel Sobrino-Márquez ,&nbsp;en representación de los Equipos Españoles de Trasplante Cardiaco ,&nbsp;Miguel Llano-Cardenal ,&nbsp;José Antonio Vázquez de Prada ,&nbsp;Francisco Nistal-Herrera ,&nbsp;Cristina Castrillo ,&nbsp;Beatriz Díaz-Molina ,&nbsp;Vanesa Alonso-Fernández ,&nbsp;Cristina Fidalgo-Muñiz ,&nbsp;Diego Rangel-Sousa ,&nbsp;Antonio Grande-Trillo ,&nbsp;Ferrán Gran-Ipiña","doi":"10.1016/j.recesp.2025.04.010","DOIUrl":"10.1016/j.recesp.2025.04.010","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>This report presents updated data on heart transplants in Spain, including procedures carried out in 2024. It reviews trends over the past decade (2015-2024) in donor and recipient characteristics, surgical techniques, immunosuppression strategies, and survival rates.</div></div><div><h3>Methods</h3><div>Data were drawn from the Spanish heart transplant registry, which is updated annually. The analysis includes 347 transplants performed in 2024, as well as procedures from 2015 to 2023 (n<!--> <!-->=<!--> <!-->2721).</div></div><div><h3>Results</h3><div>In 2024, the number of heart transplants increased by 6.8% compared with 2023. There were no significant changes in recipient age or sex, but the proportion of urgent transplants rose to 47.0%. Use of circulatory support devices increased, particularly extracorporeal membrane oxygenation. The average donor age showed a slight increase in 2024, although the long-term trend remained downward. Donation after circulatory death accounted for 29.1% of transplants in 2024. One-year survival rates improved, reaching 85.2% for transplants performed between 2021 and 2023.</div></div><div><h3>Conclusions</h3><div>The number of heart transplants continued to grow, nearing historic highs, largely due to the expansion of donation after circulatory death. Improved 1-year survival reflects the maturity of transplant programs, advances in surgical and medical management, and better pretransplant conditions in recipients.</div></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"78 10","pages":"Pages 906-915"},"PeriodicalIF":5.9,"publicationDate":"2025-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145181351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Reserva fraccional de flujo u OCT para guiar el tratamiento de estenosis coronarias complejas y no complejas angiográficamente intermedias","authors":"Andrea Zito ,&nbsp;Francesco Burzotta ,&nbsp;Cristina Aurigemma ,&nbsp;Enrico Romagnoli ,&nbsp;Francesco Bianchini ,&nbsp;Emiliano Bianchini ,&nbsp;Lazzaro Paraggio ,&nbsp;Mattia Lunardi ,&nbsp;Carolina Ierardi ,&nbsp;Filippo Crea ,&nbsp;Antonio Maria Leone ,&nbsp;Carlo Trani","doi":"10.1016/j.recesp.2025.02.016","DOIUrl":"10.1016/j.recesp.2025.02.016","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>The management of patients with coronary artery disease can benefit from devices that improve functional or anatomical evaluation. This study aimed to compare the efficacy of optical coherence tomography (OCT) and fractional flow reserve (FFR) guidance for managing vessels with angiographically intermediate coronary lesions according to angiographic lesion complexity.</div></div><div><h3>Methods</h3><div>The FORZA trial (<span><span>NCT01824030</span><svg><path></path></svg></span>) was a randomized trial comparing the use of OCT or FFR for revascularization decisions and percutaneous coronary intervention optimization in patients with angiographically intermediate coronary lesions. Complex lesions were defined as long (length &gt;<!--> <!-->38<!--> <!-->mm), severely calcified, or bifurcation lesions. The primary outcome was major adverse cardiac events (MACE), defined as a composite of all-cause death, myocardial infarction, or target vessel revascularization.</div></div><div><h3>Results</h3><div>A total of 420 vessels (200 OCT-guided and 220 FFR-guided) were enrolled, including 212 vessels with complex lesions. At the 5-year follow-up, the MACE rate was 20.8% in vessels with complex lesions and 13.9% in vessels with noncomplex lesions (HR, 1.52; 95%<span>C</span>I, 0.95-2.44; <em>P</em> <!-->=<!--> <!-->.078). Compared with FFR, OCT was associated with a lower risk of MACE in vessels with complex lesions (HR, 0.53; 95%CI, 0.28-0.98; <em>P</em> <!-->=<!--> <!-->.044), but with a higher risk of MACE in vessels with noncomplex lesions (HR, 2.23; 95%CI, 1.04-4.81; <em>P</em> <!-->=<!--> <!-->.040; <em>P</em>_interaction <!-->=<!--> <!-->.004).</div></div><div><h3>Conclusions</h3><div>In vessels with angiographically intermediate coronary lesions, angiographic lesion complexity may modulate the long-term efficacy of the guidance modality, with a potential benefit of OCT in complex lesions and FFR in noncomplex lesions.</div></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"78 10","pages":"Pages 876-885"},"PeriodicalIF":5.9,"publicationDate":"2025-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145181403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Atrioseptostomía con balón para la transposición de las grandes arterias en Europa: características y resultados actuales","authors":"Hugues Lucron ,&nbsp;Sophie-Guiti Malekzadeh-Milani ,&nbsp;Thomas Perouse de Montclos ,&nbsp;Alban-Elouen Baruteau ,&nbsp;Alberto Mendoza Soto ,&nbsp;Gianfranco Butera ,&nbsp;Ina Michel-Behnke ,&nbsp;Caroline Ovaert ,&nbsp;Carles Bautista-Rodriguez ,&nbsp;James Bentham ,&nbsp;Zakaria Jalal ,&nbsp;Pedro Betrian Blasco ,&nbsp;Hélène Bouvaist ,&nbsp;Marie Vincenti ,&nbsp;José Diego Ferreira Matins ,&nbsp;Jean-Marc Jellimann ,&nbsp;Alessia Callegari ,&nbsp;Laurent Bonnemains ,&nbsp;Ronan Bonnefoy ,&nbsp;Biagio Castaldi ,&nbsp;Damien Bonnet","doi":"10.1016/j.recesp.2024.12.014","DOIUrl":"10.1016/j.recesp.2024.12.014","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Balloon atrial septostomy (BAS) improves oxygenation in neonates with transposition of the great arteries (TGA) and restrictive foramen ovale. Currently, there is a global shortage of dedicated BAS catheters, while new unmarked catheters have recently become available at some European centers. This study aimed to characterize BAS outcomes using the currently available BAS catheters in Europe.</div></div><div><h3>Methods</h3><div>A 2-year multicenter observational registry was conducted, including all neonates undergoing BAS for TGA. We report preliminary results (September 2022-February 2024) focusing on BAS characteristics and outcomes.</div></div><div><h3>Results</h3><div>A total of 250 BAS procedures were performed in 29 centers. The median neonatal weight was 3.16<!--> <!-->kg, and 88% of neonates had a prenatal diagnosis. Most procedures were performed often on the first day of life during working hours (72.8%), mainly in catheterization laboratories (59.2%). Guidance primarily involved ultrasound with or without fluoroscopy. A guidewire was used in 41.2% of procedures. A total of 290 catheters (286 Z-5 or Z-6) were used, achieving an overall BAS success rate of 96%. Complete procedural failure was associated with the use of the umbilical venous route (OR, 3.62; <em>P</em> <!-->=<!--> <!-->.001) and lower-volume catheters (OR, 7.01; <em>P</em> <!-->&lt;<!--> <!-->.001). The occurrence of significant complications (8%; OR, 9.33; <em>P</em> <!-->&lt;<!--> <!-->.001) was associated with complete procedural failure. For complex procedures, significant risk factors were the absence of fluoroscopy (OR, 3.32; <em>P</em> <!-->=<!--> <!-->.001), use of the umbilical venous route (OR, 2.28; <em>P</em> <!-->=<!--> <!-->.005), and lower-volume catheters (OR, 2.43; <em>P</em> <!-->=<!--> <!-->.03).</div></div><div><h3>Conclusions</h3><div>In the current era, BAS can be challenging, and significant complications and complete failures are not uncommon. The use of the umbilical venous route, low-volume BAS catheters, absence of fluoroscopy guidance, and the occurrence of complications negatively impact procedural outcomes.</div></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"78 8","pages":"Pages 694-706"},"PeriodicalIF":5.9,"publicationDate":"2025-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144714367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"¿Español o castellano?","authors":"","doi":"10.1016/j.recesp.2025.04.003","DOIUrl":"10.1016/j.recesp.2025.04.003","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"78 10","pages":"Page 837"},"PeriodicalIF":5.9,"publicationDate":"2025-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145181353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impacto de la prescripción temprana de inhibidores de SGLT2 en los resultados de la insuficiencia cardiaca aguda descompensada: evidencia del mundo real","authors":"Luis E. Echeverría ,&nbsp;Lyda Z. Rojas ,&nbsp;Angie Yarlady Serrano-García ,&nbsp;Daniel R. Botero ,&nbsp;María Cantillo-Reines ,&nbsp;Adriana M. Jurado ,&nbsp;Karen Andrea García-Rueda ,&nbsp;Ángela Torres-Bustamante ,&nbsp;Diana Ivonne Cañón-Gómez ,&nbsp;Carolina Idrovo-Turbay ,&nbsp;Robinson Sánchez-García ,&nbsp;Jaime Alberto Rodríguez ,&nbsp;Sergio A. Gómez-Ochoa","doi":"10.1016/j.recesp.2025.02.009","DOIUrl":"10.1016/j.recesp.2025.02.009","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Although sodium-glucose cotransporter 2 inhibitors (SGLT2i) have shown benefits in acute decompensated heart failure (ADHF), the extrapolability of clinical trial results to general populations remains limited. This study evaluated the impact of early in-hospital SGLT2i prescription on ADHF outcomes in a real-world setting.</div></div><div><h3>Methods</h3><div>Prospective cohort study. Adults with ADHF from a third-level cardiovascular center were included. The primary analysis compared early SGLT2i (prescribed within 48<!--> <!-->hours of admission) versus late SGLT2i (prescribed after 48<!--> <!-->hours). A secondary analysis included patients not receiving in-hospital SGLT2i. The primary outcome was in-hospital mortality. Secondary outcomes included the length of hospital stay, 30-day improvement in the Minnesota Living with Heart Failure Questionnaire score, 30-day rehospitalization due to heart failure, and 30-day all-cause mortality.</div></div><div><h3>Results</h3><div>Of 2016 patients, early SGLT2i (≤<!--> <!-->48<!--> <!-->h) was initiated in 1275 (63.2%) patients, late SGLT2i in 346 (17.2%), and 395 (19.6%) did not receive in-hospital SGLT2i. After multivariate adjustment, early versus late SGLT2i use was associated with decreased in-hospital mortality (RR, 0.37; 95%CI, 0.17-0.77) and reduced hospital stay (mean difference −5.70 days; 95%CI, −7.05 to −4.34). Similarly, early versus late or no in-hospital SGLT2i use was associated with decreased in-hospital mortality (RR, 0.25; 95%CI, 0.14-0.44), reduced hospital stay (mean difference −2.99 days; 95%CI, −4.05 to −1.92), and lower 30-day combined mortality/heart failure rehospitalization (RR, 0.72; 95%CI, 0.53-0.98).</div></div><div><h3>Conclusions</h3><div>Early in-hospital SGLT2i prescription was associated with improved cardiovascular outcomes in ADHF in a real-world setting.</div></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"78 9","pages":"Pages 780-788"},"PeriodicalIF":5.9,"publicationDate":"2025-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144895204","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Implante percutáneo de válvula aórtica en válvulas aórticas bicúspides: presente y futuro","authors":"Alberto Alperi ,&nbsp;Raquel del Valle ,&nbsp;Isaac Pascual ,&nbsp;Paula Antuna ,&nbsp;Marcel Almendárez ,&nbsp;Rut Álvarez ,&nbsp;Daniel Hernández-Vaquero ,&nbsp;Pablo Avanzas","doi":"10.1016/j.recesp.2025.02.013","DOIUrl":"10.1016/j.recesp.2025.02.013","url":null,"abstract":"<div><div>The prevalence of bicuspid aortic valves (BAV) in patients undergoing transcatheter aortic valve implantation (TAVI) is expected to gradually increase over the coming years. However, in the absence of dedicated randomized trials, TAVI outcomes in BAV patients have failed to match those obtained in trileaflet anatomies. This discrepancy is mainly due to varying degrees of valve morphology and calcification, aortic angulation, concomitant aortopathy, and the difficulties of achieving optimal preprocedural anatomic sizing and device selection in the BAV setting. In this review, we aim to outline the current state of knowledge in the BAV and TAVI field, evaluate the main challenges faced by TAVI operators when dealing with these anatomies, summarize novel approaches for sizing and preprocedural evaluation, and provide a glimpse into the future of this interesting and evolving field.</div></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"78 8","pages":"Pages 724-735"},"PeriodicalIF":5.9,"publicationDate":"2025-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144714370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}